HealthEquity Good Will from 2010 to 2024

HQY Stock  USD 103.57  0.19  0.18%   
HealthEquity Good Will yearly trend continues to be fairly stable with very little volatility. Good Will is likely to outpace its year average in 2024. Good Will is an intangible asset that arises when HealthEquity acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2013-01-31
Previous Quarter
1.6 B
Current Value
1.6 B
Quarterly Volatility
765.3 M
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Good Will Growth Pattern

Below is the plot of the Good Will of HealthEquity over the last few years. It is an intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. HealthEquity's Good Will historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Good Will10 Years Trend
Slightly volatile
   Good Will   
       Timeline  

HealthEquity Good Will Regression Statistics

Arithmetic Mean658,817,456
Geometric Mean48,349,466
Coefficient Of Variation128.34
Mean Deviation784,999,747
Median4,651,000
Standard Deviation845,495,352
Sample Variance714862.4T
Range2B
R-Value0.88
Mean Square Error171981.5T
R-Squared0.78
Significance0.000014
Slope166,608,111
Total Sum of Squares10008073.5T

HealthEquity Good Will History

2024B
20231.9 B
20221.6 B
20211.6 B
20201.3 B
20191.3 B

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Good Will, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Good Will1.9 BB

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.